# Amphastar Pharmaceuticals, Inc.: Form 8-K, filed Jun 6, 2023

- Company: [Amphastar Pharmaceuticals, Inc.](/companies/amph.md) (CIK 1297184)
- Form: 8-K
- Filed: 2023-06-06
- Accepted by EDGAR: Jun 5, 2023, 18:32 ET
- Period: 2023-06-05
- Accession: 0001297184-23-000053
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/amph-20230605x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/amph-20230605x8k.htm

Filed Jun 6, 2023.
Source: SEC EDGAR, the filing index for accession 0001297184-23-000053. Last ingested by Listed: Nov 6, 2026, 17:01 ET. No prices; not investment advice.
